Publication:
SEOM clinical guideline for the management of malignant melanoma (2017).

Simple item page
dc.contributor.authorBerrocal, A
dc.contributor.authorArance, A
dc.contributor.authorCastellon, V E
dc.contributor.authorde la Cruz, L
dc.contributor.authorEspinosa, E
dc.contributor.authorCao, M G
dc.contributor.authorLarriba, J L G
dc.contributor.authorMárquez-Rodas, I
dc.contributor.authorSoria, A
dc.contributor.authorAlgarra, S M
dc.date.accessioned2023-01-25T10:01:19Z
dc.date.available2023-01-25T10:01:19Z
dc.date.issued2017-11-07
dc.description.abstractAll melanoma suspected patients must be confirmed histologically and resected. Sentinel node biopsy must be done when tumor is over 1 mm or if less with high-risk factors. Adjuvant therapy with interferon could be offered for patients with high-risk melanoma and in selected cases radiotherapy can be added. Metastatic melanoma treatment is guided by mutational BRAF status. BRAF wild type patients must receive anti-PD1 containing therapy and BRAF mutated patients BRAF/MEK inhibitors or anti-PD1 containing therapy. Up to 10 years follow up is reasonable for melanoma patients with dermatologic examinations and physical exams.
dc.identifier.doi10.1007/s12094-017-1768-1
dc.identifier.essn1699-3055
dc.identifier.pmcPMC5785602
dc.identifier.pmid29116432
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785602/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s12094-017-1768-1.pdf
dc.identifier.urihttp://hdl.handle.net/10668/11780
dc.issue.number1
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationHospital Torrecárdenas
dc.organizationHospital Universitario Virgen Macarena
dc.page.number69-74
dc.pubmedtypeJournal Article
dc.pubmedtypePractice Guideline
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAdjuvant
dc.subjectB-RAF
dc.subjectImmunotherapy
dc.subjectMelanoma
dc.subjectMetastatic
dc.subject.meshCombined Modality Therapy
dc.subject.meshHumans
dc.subject.meshMelanoma
dc.titleSEOM clinical guideline for the management of malignant melanoma (2017).
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number20
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC5785602.pdf
Size:
351.8 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Torrecárdenas
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía